APA (7th ed.) Citation

Li, H., Zhang, R., Sui, T., Wang, K., Li, Y., Luo, X., & He, Q. (2025). Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer. Cancers, 17(18), 2986. https://doi.org/10.3390/cancers17182986

Chicago Style (17th ed.) Citation

Li, Hu, Ruonan Zhang, Tiantian Sui, Kai Wang, Yiran Li, Xuezhen Luo, and Qizhi He. "Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer." Cancers 17, no. 18 (2025): 2986. https://doi.org/10.3390/cancers17182986.

MLA (9th ed.) Citation

Li, Hu, et al. "Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer." Cancers, vol. 17, no. 18, 2025, p. 2986, https://doi.org/10.3390/cancers17182986.